Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121626118 | 12162611 | 8 | F | 20160706 | 20160309 | 20160714 | PER | US-PFIZER INC-2016128114 | PFIZER | 82.00 | YR | M | Y | 83.00000 | KG | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121626118 | 12162611 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (ONCE DAILY, 28 DAYS ON/14 DAYS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 121626118 | 12162611 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (ONCE DAILY, 28 DAYS ON/14 DAYS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 121626118 | 12162611 | 3 | C | PROSCAR | FINASTERIDE | 1 | UNK | 0 | |||||||||||
| 121626118 | 12162611 | 4 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 121626118 | 12162611 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 121626118 | 12162611 | 6 | C | COLACE | DOCUSATE SODIUM | 1 | UNK | 0 | |||||||||||
| 121626118 | 12162611 | 7 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 121626118 | 12162611 | 8 | C | POTASSIUM | POTASSIUM | 1 | UNK | 0 | |||||||||||
| 121626118 | 12162611 | 9 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 121626118 | 12162611 | 10 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121626118 | 12162611 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121626118 | 12162611 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121626118 | 12162611 | Acne | |
| 121626118 | 12162611 | Appetite disorder | |
| 121626118 | 12162611 | Dysgeusia | |
| 121626118 | 12162611 | Fatigue | |
| 121626118 | 12162611 | Glossitis | |
| 121626118 | 12162611 | Head discomfort | |
| 121626118 | 12162611 | Hypersomnia | |
| 121626118 | 12162611 | Insomnia | |
| 121626118 | 12162611 | Platelet count decreased | |
| 121626118 | 12162611 | Pruritus | |
| 121626118 | 12162611 | Renal impairment | |
| 121626118 | 12162611 | Scab | |
| 121626118 | 12162611 | Skin lesion | |
| 121626118 | 12162611 | Tongue disorder | |
| 121626118 | 12162611 | Urinary tract infection | |
| 121626118 | 12162611 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121626118 | 12162611 | 1 | 20160208 | 20160306 | 0 | |
| 121626118 | 12162611 | 2 | 20160404 | 20160418 | 0 | |
| 121626118 | 12162611 | 7 | 201505 | 20160629 | 0 |